H.R. 5316
HouseDrug Shortage Compounding Patient Access Act of 2025
Sponsor: Rep. Diana Harshbarger (R-TN)
The bill has been introduced and is awaiting committee action.
In brief
This legislation allows pharmacists and compounding facilities to produce essential medications during declared national drug shortages without certain traditional regulatory restrictions. It aims to ensure that patients have continuous access to life-saving drugs when commercial supplies are unavailable. The bill responds to persistent supply chain vulnerabilities in the pharmaceutical industry.
Timeline
Every recorded action, oldest first.
June 21, 2026 · House
Introduced
The bill eases regulations on compounded drugs to mitigate the impact of national pharmaceutical shortages on patients.
Next: Referred to the House Committee on Energy and Commerce.
Source